Instructions for Symbicort Turbuhaler (budesonide, formoterol) Powder
English Product Name
Symbicort Turbuhaler
Dosage form
powder d/ inhalation metered dose 80 μg + 4.5 μg / 1 dose: inhalers 60 doses or 120 doses
powder d/ inhalation metered dose 160 μg + 4.5 μg / 1 dose: inhalers 60 doses or 120 doses
Description Symbicort Turbuhaler:
Powder for inhalation metered; the contents of the inhaler* are granules from white to almost white, mainly rounded in shape.
1 dose
micronized budesonide 160 μg
formoterol fumarate dihydrate 4.5 mcg
Excipients: lactose monohydrate - 730 mcg.
60 doses - plastic inhalers* with first opening control (protective film indicating the place of opening) (1) - cardboard packs.
120 doses - plastic inhalers* with first opening control (protective film indicating the place of opening) (1) - cardboard packs.
Turbuhaler® inhaler, consisting of a metering device, a powder storage tank, a desiccant tank, a mouthpiece and a screw-on lid. Inhaler: a rotating red metering meter on which braille code is embossed; white cover; on the inside of the lid there are 5 ribbed thickenings in the form of longitudinal strips; in the metering indicator window, the number "60" or "120" is visible for the inhaler at 60 or 120 doses, respectively; the mouthpiece has four longitudinal ribs and can rotate.
ATX Codes
R03AK07 Formoterol and Budesonide
Clinical and pharmacological groups / Group affiliation
Combined bronchodilator - selective beta2-adrenomimetic + topical glucocorticosteroid
Active ingredient
budesonide
formoterol fumarate dihydrate
Pharmaco-therapeutic group
Bronchodilating agent (selective beta2-adrenomimetic + topical glucocorticosteroid)
Storage conditions
The drug should be stored out of the reach of children at a temperature not exceeding 30 ° C.
Shelf life
Shelf life - two years. Do not use after the expiration date.
pharmachologic effect Symbicort Turbuhaler:
Symbicort® contains budesonide and formoterol, which have different mechanisms of action and show an additive effect in reducing the frequency of exacerbations of bronchial asthma. The special properties of budesonide and formoterol make it possible to use their combination to relieve attacks / symptoms with anti-inflammatory action, or as a supportive therapy for bronchial asthma.
Testimony Symbicort Turbuhaler:
- Dose 80/4.5 mcg
- bronchial asthma, to achieve overall disease control,
- including prevention and relief of symptoms,
- and reducing the risk of exacerbations.
- Dose 160/4.5 mcg
- bronchial asthma, to achieve overall disease control, including prevention and relief of symptoms, and reducing the risk of exacerbations. Symbicort® Turbuhaler® is suitable
- for the treatment of bronchial asthma of any severity, if it is advisable to use inhaled corticosteroids;
- COPD, as symptomatic therapy in patients with post-bronchodilation FEV1 <70% of the due and with a history of exacerbations, despite regular therapy with bronchodilators.
Dosage, Course and Dosage Symbicort Turbuhaler:
For inhalation use.
Dose 80/4.5 mcg
Symbicort® is not intended for the initial treatment of bronchial asthma.
Selection of the dose of drugs that make up the drug Symbicort® is carried out individually and depending on the severity of the disease. This must be taken into account not only when starting treatment with combined drugs, but also when changing the maintenance dose of the drug.
Patients should be under the constant supervision of a doctor for adequate selection of the dose of Symbicort® Turbuhaler®.
- Nosology Symbicort Turbuhaler (ICD codes)
- J44
- Another chronic obstructive pulmonary disease
- J45
- Asthma
